2r4f: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
{{Seed}}
[[Image:2r4f.png|left|200px]]
[[Image:2r4f.png|left|200px]]


Line 19: Line 18:
{{ABSTRACT_PUBMED_18072721}}
{{ABSTRACT_PUBMED_18072721}}


==Disease==
==About this Structure==
Known disease associated with this structure: Statins, attenuated cholesterol lowering by OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=142910 142910]]
[[2r4f]] is a 4 chain structure of [[HMG-CoA Reductase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2R4F OCA].


==About this Structure==
==See Also==
2R4F is a 4 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2R4F OCA].
*[[HMG-CoA Reductase]]


==Reference==
==Reference==
Line 49: Line 48:
[[Category: Sterol biosynthesis]]
[[Category: Sterol biosynthesis]]
[[Category: Transmembrane]]
[[Category: Transmembrane]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Feb 17 23:32:17 2009''

Revision as of 23:45, 26 December 2010

File:2r4f.png

Template:STRUCTURE 2r4f

Substituted Pyrazoles as Hepatselective HMG-COA reductase inhibitors

Template:ABSTRACT PUBMED 18072721

About this Structure

2r4f is a 4 chain structure of HMG-CoA Reductase with sequence from Homo sapiens. Full crystallographic information is available from OCA.

See Also

Reference

  1. Pfefferkorn JA, Choi C, Larsen SD, Auerbach B, Hutchings R, Park W, Askew V, Dillon L, Hanselman JC, Lin Z, Lu GH, Robertson A, Sekerke C, Harris MS, Pavlovsky A, Bainbridge G, Caspers N, Kowala M, Tait BD. Substituted pyrazoles as hepatoselective HMG-CoA reductase inhibitors: discovery of (3R,5R)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H -pyrazol-3-yl]-3,5-dihydroxyheptanoic acid (PF-3052334) as a candidate for the treatment of hypercholesterolemia. J Med Chem. 2008 Jan 10;51(1):31-45. Epub 2007 Dec 12. PMID:18072721 doi:10.1021/jm070849r

Proteopedia Page Contributors and Editors (what is this?)

OCA